Literature DB >> 25025347

Inhaled interferon: a novel treatment for virus-induced asthma?

Daniel J Jackson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25025347      PMCID: PMC4226059          DOI: 10.1164/rccm.201406-1131ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  16 in total

1.  Lower airway rhinovirus burden and the seasonal risk of asthma exacerbation.

Authors:  Loren C Denlinger; Ron L Sorkness; Wai-Ming Lee; Michael D Evans; Michele J Wolff; Sameer K Mathur; Gina M Crisafi; Katie L Gaworski; Tressa E Pappas; Rose F Vrtis; Elizabeth A Kelly; James E Gern; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

2.  Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma.

Authors:  Y A Bochkov; K M Hanson; S Keles; R A Brockman-Schneider; N N Jarjour; J E Gern
Journal:  Mucosal Immunol       Date:  2009-08-26       Impact factor: 7.313

3.  Innate IFNs and plasmacytoid dendritic cells constrain Th2 cytokine responses to rhinovirus: a regulatory mechanism with relevance to asthma.

Authors:  Antonia L Pritchard; Melanie L Carroll; Julie G Burel; Olivia J White; Simon Phipps; John W Upham
Journal:  J Immunol       Date:  2012-05-18       Impact factor: 5.422

4.  Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.

Authors:  William W Busse; Wayne J Morgan; Peter J Gergen; Herman E Mitchell; James E Gern; Andrew H Liu; Rebecca S Gruchalla; Meyer Kattan; Stephen J Teach; Jacqueline A Pongracic; James F Chmiel; Suzanne F Steinbach; Agustin Calatroni; Alkis Togias; Katherine M Thompson; Stanley J Szefler; Christine A Sorkness
Journal:  N Engl J Med       Date:  2011-03-17       Impact factor: 91.245

5.  Role of deficient type III interferon-lambda production in asthma exacerbations.

Authors:  Marco Contoli; Simon D Message; Vasile Laza-Stanca; Michael R Edwards; Peter A B Wark; Nathan W Bartlett; Tatiana Kebadze; Patrick Mallia; Luminita A Stanciu; Hayley L Parker; Louise Slater; Anita Lewis-Antes; Onn M Kon; Stephen T Holgate; Donna E Davies; Sergei V Kotenko; Alberto Papi; Sebastian L Johnston
Journal:  Nat Med       Date:  2006-08-13       Impact factor: 53.440

6.  Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells.

Authors:  Michelle A Gill; Gagan Bajwa; Tiffany A George; Caroline C Dong; Irene I Dougherty; Nan Jiang; Vanthaya N Gan; Rebecca S Gruchalla
Journal:  J Immunol       Date:  2010-04-21       Impact factor: 5.422

7.  In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects.

Authors:  Nilceia Lopez-Souza; Silvio Favoreto; Hofer Wong; Theresa Ward; Shigeo Yagi; David Schnurr; Walter E Finkbeiner; Gregory M Dolganov; Jonathan H Widdicombe; Homer A Boushey; Pedro C Avila
Journal:  J Allergy Clin Immunol       Date:  2009-05-09       Impact factor: 10.793

8.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program.

Authors:  Wendy C Moore; Deborah A Meyers; Sally E Wenzel; W Gerald Teague; Huashi Li; Xingnan Li; Ralph D'Agostino; Mario Castro; Douglas Curran-Everett; Anne M Fitzpatrick; Benjamin Gaston; Nizar N Jarjour; Ronald Sorkness; William J Calhoun; Kian Fan Chung; Suzy A A Comhair; Raed A Dweik; Elliot Israel; Stephen P Peters; William W Busse; Serpil C Erzurum; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2009-11-05       Impact factor: 21.405

9.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.

Authors:  Peter A B Wark; Sebastian L Johnston; Fabio Bucchieri; Robert Powell; Sarah Puddicombe; Vasile Laza-Stanca; Stephen T Holgate; Donna E Davies
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

Review 10.  Asthma exacerbations: origin, effect, and prevention.

Authors:  David J Jackson; Annemarie Sykes; Patrick Mallia; Sebastian L Johnston
Journal:  J Allergy Clin Immunol       Date:  2011-12       Impact factor: 10.793

View more
  2 in total

1.  In vivo reprogramming of pathogenic lung TNFR2+ cDC2s by IFNβ inhibits HDM-induced asthma.

Authors:  Samira Mansouri; Himanshu Gogoi; Mauricio Pipkin; Tiago N Machuca; Amir M Emtiazjoo; Ashish K Sharma; Lei Jin
Journal:  Sci Immunol       Date:  2021-07-09

2.  Lung IFNAR1hi TNFR2+ cDC2 promotes lung regulatory T cells induction and maintains lung mucosal tolerance at steady state.

Authors:  Samira Mansouri; Divya S Katikaneni; Himanshu Gogoi; Mauricio Pipkin; Tiago N Machuca; Amir M Emtiazjoo; Lei Jin
Journal:  Mucosal Immunol       Date:  2020-01-20       Impact factor: 7.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.